维普期刊资源整合服务平台（V6.5）

199篇 您的检索式：作者名="Bensinger"

选中清除导出查看参考文献查看引证文献引用追踪共10页首页上一页第1页下一页末页 /10 跳转

	题名	作者	年代	出处	被引量
1	Distinct IL-2 receptorsignaling pattern in CD4 + CD25 + regulatory T cells显示文摘	Bensinger SJ Walsh PT Zhang J	2004	J Immu-nol2004，172，9：	1
2	Improving stem cell mobilization strategies: future directions 显示文摘	Bensinger W DiPersio JF McCarty JM	2009	Bone MarrowTransplant2009，43，3：	1
3	Engraftment afler infusion of CD34^+ marrow cells in patients with breast cancer or neuroblastoma 显示文摘	Berenson RJ Bensinger WI Hill RS	1991	Blood1991，77，8：	1
4	Treatment of nomal donors with recombinant growth factors for transplantation of allogeneic blood stem cells显示文摘	Bensinger W Buckner CD Rowley S	1996	Bone Marrow Transplant1996，17，2：	1
5	Distinct IL-2 receptor signaling pattern in CD4 CD25 regulatory T cells 显示文摘	BENSINGER S J WALSH P T ZHANG J	2004	J Immunol2004，172，9：	1
6	Phase 1 study of weekly dosing with the investigational oral proteasome inhibitor ixazomib in relapsed / refractory multiple myeloma 显示文摘	Kumar SK Bensinger WI Zimmerman TM	2014	Blood2014，124，7：	1
7	Phase 1 study of weekly dosing with the investigational oral proteasome inhibitor ixazomib in relapsed~refractory multiple myeloma显示文摘	Kumar SK Bensinger WI Zimmerman TM	2014	Blood2014，124，7：	1
8	Safety of granulocyte colony-stimulating factor in normal donors显示文摘	Gutierrez-Ddgado F Bensinger W	2001	Curr Opin Hematol2001，8，：	1
9	Palifermin for oral mucositic after intensive therapy for hematologic cancers 显示文摘	Spielberger R Stiff P Bensinger W	2004	N Engl J Med2004，351，25：	1
10	Apoptotic cells promote their own clearance and immune tolerance through activation of the nuclear receptor LXR显示文摘	Gonzalez N A Bensinger S J Hong C		0，，：	1
11	NCCN clinical practice guidelines in oncology : multiple myeloma 显示文摘	Anderson KC Alsina M Bensinger W	2009	J Natl Compr Canc Netw2009，7，9：	1
12	Palifermin for oral mueositis after intensive therapy for hematologic cancers 显示文摘	Spielberger R Stiff P Bensinger W	2004	N Engl J Med2004，351，25：	1
13	Palifermin for oral mucositis after intensive therapy for hematologic cancers显示文摘	Spielberger R Stiff P Bensinger W	2004	N Engl J Med2004，351，25：	1
14	Liver X receptor and peroxisome proliferator activated receptor as integrators of lipid homeostasis and immunity显示文摘	Kidani Y Bensinger S J		0，，：	1
15	Abdominal sacral suspensions:Analysis of complications using permanent mesh显示文摘	Bensinger G Lind L Guess M	2005	Am J Obstet Gynecol2005，193，6：	1
16	Engraflraent after infus- ion of CD34+ marrow cells in patients with breast cancer or neur- oblastoma显示文摘	Berenson R J Bensinger W I Hill RS	1991	Blood1991，77，8：	1
17	Abdominal sacralsuspensions : analysis of complications using permanent mesh 显示文摘	Bensinger G Lind L Guess M	2005	Am J Obstet Gynecol2005，193，6：	1
18	Veno-occlusive disease of the liver after busulfan, melphalan, and thiotepa conditioning therapy: incidence, risk factors, and outcome显示文摘	Lee JL Gooley T Bensinger W	1999	Biol Blood Marrow Transplant1999，5，5：	1
19	Distinct IL-2 receptor signaling pattern in CD4 + CD25 + regulatory T cells显示文摘	Bensinger S J Walsh P T ZHANG J	2004	J Immunol2004，172，9：	1
20	Ricolinostat ( ACY- 1215 ), the first selective HDAC6 inhibitor, in combonation with Jenalidomide and dexamethasone in patients with relapsed and relapsed-and-refractory multiple myeloma: phase lb results ( ACE- MM-101 study ) 显示文摘	Yee A J Bensinger W Voorhees PM	2015	Blood2015，126，23：	1

返回顶部每页显示：

共10页首页上一页第1页下一页末页 /10 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示